Aeglea BioTherapeutics AGLE

$ 12.01 0.0%

Annual report 2023
added 11-18-2024

Aeglea BioTherapeutics EV/EBITDA Ratio 2011-2024 | AGLE

Annual EV/EBITDA Ratio Aeglea BioTherapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-4.27	-4.38	-2.59	-3.65	-3.32	0.39	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.39	-4.38	-2.97